Solimastat

DB19872ExperimentalSmall molecule

Solimastat is a small molecule drug. The usage of the INN stem '-mastat' in the name indicates that Solimastat is a matrix metalloproteinase inhibitor. Solimastat has a monoisotopic molecular weight...

Formula / weight: C₂₀H₃₂N₄O₅ · 408.499 g/mol (avg)
Code names: BB-3644

Resolves to

Compound

UNII414MEG73VUCAS226072-63-5ChEMBLCHEMBL2107228

Structure

InChIKeyWORSVFBVUCBRIP-VNQPRFMTSA-NSMILESCO[C@@H]([C@@H](CC(C)C)C(=O)N[C@H](C(=O)NC1=NC=CC=C1)C(C)(C)C)C(=O)NO

Targets

P09237MMP7P08253MMP2P03956MMP1

What you can answer from here — as of September 19, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Solimastat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account